Sales & Marketing News | pharmaphorum

News

CMS update on Alzheimer's coverage raises questions

The Centres for Medicare and Medicaid Services (CMS) has formally announced its intention to allow coverage of new amyloid-targeting drugs for Alzheimer’s disease if they

News

Lonza builds its ADC capacity with Synaffix takeover

Lonza has boosted its ability to cater for customers in the fast-emerging antibody-drug conjugate category with a deal to buy Dutch company Synaffix and its platform techn

News

AZ drops IL-23 drug for inflammatory bowel disease

AstraZeneca has taken a look at the competition emerging in the market for inflammatory bowel disease (IBD) therapies, and decided to shelve a project that had advanced in

News

After FDA nod, Pfizer joins GSK in RSV vaccine market

The FDA has approved Pfizer’s respiratory syncytial virus (RSV) vaccine for older adults, just a few weeks after a rival shot from GSK became the first to be cleared in th

News

Bayer bets on digital to deliver ‘precision’ consumer health

Personalised and precision health is a firmly established concept in the development of new prescription medicines, but not so much in the consumer health category.

News

Elizabeth Holmes due to start prison sentence today

After years of legal wrangling, former Theranos chief executive Elizabeth Holmes is due to report later today at a federal prison, where she will start serving an 11-year

CMS update on Alzheimer's coverage raises questions

Lonza builds its ADC capacity with Synaffix takeover

AZ drops IL-23 drug for inflammatory bowel disease

After FDA nod, Pfizer joins GSK in RSV vaccine market

Bayer bets on digital to deliver ‘precision’ consumer health

Elizabeth Holmes due to start prison sentence today

Sanofi drops two more programmes in R&D clear-out

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks